Self-reported COVID-19 prevalence among isotretinoin users vs. non-users: a cross-sectional survey
Open Access
- 26 October 2025
- journal article
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 5 (4) , 234-239
Abstract
Aim: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic, and effective drug treatments for COVID-19 remain unavailable. Isotretinoin (ISO), a retinoic acid derivative commonly used for severe acne, is a potent down-regulator of ACE2 receptors, which play a key role in the pathophysiology of COVID-19. This study aims to investigate the effect of ISO treatment on COVID-19 infection in patients with acne vulgaris. Materials and Methods: Between January 2021 and April 2021, 520 ISO users with acne vulgaris and 400 controls were included in the study. Data were collected using an electronic questionnaire distributed via social media, e-mail and mobile phones. Results: Among ISO users, 66 (12.7%) had COVID-19 compared to 89 (22.3%) in the control group, indicating a significantly lower infection rate in the ISO group (pKeywords
This publication has 22 references indexed in Scilit:
- Prescribing and Dispensing of Oral Isotretinoin and Noncompliance with Recommendations in France before and during the COVID‐19 PandemicDermatology and Therapy, 2025
- Evaluating the therapeutic effects of isotretinoin on patients with coronavirus disease 2019 (COVID-19): A controlled open-label clinical trialHeliyon, 2024
- Interleukin-17A (IL-17A): A silent amplifier of COVID-19Biomedicine & Pharmacotherapy, 2021
- Oral isotretinoin treatment in patients with acne vulgaris during the COVID-19 pandemic: A retrospective cohort study in a tertiary care hospitalJournal of Cosmetic Dermatology, 2021
- Is systemic isotretinoin use a risk factor for coronavirus disease 2019 (COVID‐19)?Journal of Cosmetic Dermatology, 2021
- Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directionsArchives of Dermatological Research, 2020
- Isotretinoin is active in the initial management of acute pro-myelocytic leukemiaLeukemia Research Reports, 2020
- The effect of low-dose isotretinoin therapy on serum androgen levels in women with acne vulgarisInternational Journal of Women's Dermatology, 2019
- Immunoregulatory effects of isotretinoin in patients with acneBritish Journal of Dermatology, 2012
- Influence of isotretinoin on nasal mucociliary clearance and lung function in patients with acne vulgarisInternational Journal of Dermatology, 2009